Brief: Catalyst Biosciences Inc- On Feb 16, Co Received Notice From Nasdaq That Co Is Not In Compliance With Minimum Bid Price Requirement
18/02/2022 21:25
Feb 18 (Reuters) - Catalyst Biosciences Inc CBIO.O :
* CATALYST BIOSCIENCES INC- ON FEB 16, CO RECEIVED NOTICE
FROM
NASDAQ THAT CO IS NOT IN COMPLIANCE WITH MINIMUM BID PRICE
REQUIREMENT
Source: [https://bit.ly/3s0yxCA]
Further company coverage: CBIO.O
Recent news on Gyre Therapeutics
See all newsBrief: Gyre Therapeutics - Enters Employment Agreement With Ying Luo As CEO - SEC Filing
Gyre Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Gyre Therapeutics, Inc. expected to post a loss of 13 cents a share - Earnings Preview
Brief: Gyre Therapeutics Reports Second Quarter 2026
Gyre Therapeutics Q2 revenue beats estimates on higher ETUARY sales volumes